EXEL
Exelixis, Inc. · Healthcare
EVP, Research, Development Dana Aftab sold $1.3M of Exelixis, Inc.
Sold$1,324,868
$44.35Price
29,873Shares
−4%Stake
What EXEL did after the filing
- The stock from Mon, Feb 23 close, $44.01
- 0.0%
- S&P 500, same days
- −3.4%
Measured over 30 trading days, to the Apr 7 close.
Traded Thu, Feb 19. Filed Mon, Feb 23, 1:50 PM ET, during the session. Returns use the Feb 23 close and the Apr 7 close. Not investment advice.